MedPath

The effect of Commiphora mukul cream improvement of breast engorgement

Phase 2
Conditions
Breast engorgement.
Breast engorgement of newborn
Registration Number
IRCT2017062633812N2
Lead Sponsor
Vice Chancellor for research Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
105
Inclusion Criteria

The study inclusion criteria for the Iranian; literate mothers
who were in the 1st to 15th days after delivery consisted of having
breast engorgement with a minimum intensity score of 2 based
on the checklist (with a maximum score of 19); A sublingual temperature
below 38 ° C; Having had engorgement symptoms during the first
15 days after delivery; No use of medications for stopping breastfeeding;
No use of topical herbal therapies; Not having developed breast
abscess or mastitis; No prohibition on lactation; No history of any
allergies to Commiphora mukul or other plants; And nursing every 2 to 3 hours.
For the neonates, the inclusion criteria consisted of being a singleton
and having a full-term birth and normal birth weight (2500-4000 g);
Being able to suck on nipples; Not being prohibited from breastfeeding;
?And demanding to be nursed every 2 to 3 hours. The study exclusion criteria for the mothers consisted of the incidence of allergy to Commiphoramukul; A general temperature exceeding 38 ° C after beginning the intervention; Use or need to antiinflammatory medications or painkillers or warm compress or cold compress or acupressure interfering with the designed intervention during the course of the study; And the incidence of unexpected events for either participants interfering with their breastfeeding; Use of the proposed treatment less than five times a day. The infants were excluded from the study if they lost the study inclusion criteria for any reason, including getting a fever during the
course of the intervention.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Erythema breast. Timepoint: Before intervention,2 days after intervention. Method of measurement: Check list of breast engorgement.;Breast Tension. Timepoint: Before intervention,2 days after intervention. Method of measurement: Check list of breast engorgement.;Breast pain. Timepoint: Before intervention,2 days after intervention. Method of measurement: Check list of breast engorgement.;Total score breast engorgement. Timepoint: Before intervention,2 days after intervention. Method of measurement: Check list of breast engorgement.
Secondary Outcome Measures
NameTimeMethod
Side effects of commiphora mukul cream. Timepoint: Before intervention,2 days after intervention. Method of measurement: Q&A; Visual analog.
© Copyright 2025. All Rights Reserved by MedPath